Form 4: RA Capital Converts Preferred Stock to Common in Cidara Therapeutics

RA Capital Management converted Series A Preferred Stock to common stock in Cidara Therapeutics after the satisfaction of convertibility conditions.

Summary

• RA Capital Management, L.P., along with related entities and individuals, filed a Form 4 detailing changes in beneficial ownership of Cidara Therapeutics, Inc. [CDTX] securities.
• On July 19, 2024, 703,080 shares of common stock were acquired due to the conversion of Series A Preferred Stock.
• The conversion was triggered by the satisfaction of Convertibility Conditions on July 18, 2024, which included stockholder approval and the filing of an amendment to the certificate of incorporation.
• The Series A Preferred Stock was originally acquired on April 24, 2024, but was not convertible until the Convertibility Conditions were met.
• Each share of Series A Preferred Stock is convertible into common stock at a rate of $1,000 plus unpaid dividends, divided by a conversion price of $14.20 per share, subject to adjustments.
• RA Capital Management, L.P. serves as the investment manager for RA Capital Healthcare Fund, L.P.
• Peter Kolchinsky and Rajeev Shah, managing members of RA Capital Management GP, LLC, disclaim beneficial ownership except to the extent of their pecuniary interest.
• Laura Tadvalkar, a Managing Director of the Adviser, serves on the Issuer's board of directors.

Sentiment

Score: 6

Explanation: The document is a standard regulatory filing, indicating a procedural event (conversion of stock) rather than a fundamental change in the company's prospects. The sentiment is neutral to slightly positive as the conversion was triggered by the satisfaction of certain conditions.

Positives

• The conversion of preferred stock to common stock simplifies the capital structure of Cidara Therapeutics.
• The satisfaction of the Convertibility Conditions indicates progress and potentially positive developments for the company.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by insiders, providing transparency to the market.

Stakeholder Impact

• The conversion of preferred stock to common stock may dilute existing shareholders' ownership.

Key Dates